Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;26(7):935-940.
doi: 10.1002/lt.25747. Epub 2020 Apr 30.

Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis

Michael Krowka  1 , Emmanuelle Cottreel  2 , Marius M Hoeper  3 , Nick H Kim  4 , Nicolas Martin  2 , Olivier Sitbon  5   6   7 , Jaume Bosch  8   9
Affiliations

Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis

Michael Krowka et al. Liver Transpl. 2020 Jul.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Percentage of patients with improved perioperative and wait‐list mortality risk categorization at week 12 versus baseline.
See this image and copyright information in PMC

Comment in

References

    1. Krowka MJ, Miller DP, Barst RJ, Taichman D, Dweik RA, Badesch DB, McGoon MD. Portopulmonary hypertension: a report from the US‐based REVEAL Registry. Chest 2012;141:906‐915. - PubMed
    1. Savale L, Manes A. Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease. Eur Heart J Suppl 2019;21(suppl K): K37‐K45. - PMC - PubMed
    1. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary‐related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000;6:443‐450. - PubMed
    1. Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MAE, et al. International Liver Transplant Society Practice Guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation 2016;100:1440‐1452. - PubMed
    1. DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, et al. Predictors of waitlist mortality in portopulmonary hypertension. Transplantation 2017;101:1609‐1615. - PMC - PubMed

Publication types